I spent nine years across two global pharmaceutical multinationals, seven roles, individual contributor through to people management. Brand and commercial work across more than 40 markets, alongside executive leadership on brand lifecycles, milestone launches and global campaigns. Then health equity and social responsibility at a corporate foundation, building patient wellness hubs in underserved communities and working directly with the WHO-Foundation and UNICEF.
I am not a commentator on this work. I have managed launches carrying more than a dozen cross-functional workstreams, built first-of-their-kind pharmacy and trade activation across 1,500 outlets, negotiated commercial partnerships, and built the measurement systems that carry programmes through board and regulatory scrutiny. When I talk about access, I mean pharmacy channels, cold chains, last-mile distribution and the operational reality of getting care to people.
And the work that changed how I think was not in a boardroom. It was in the field, watching patients with chronic disease make hours of round trips for a three-minute consultation, struggle to get medicines on time, and miss treatment cycles, not because the medicine did not exist but because their most basic needs were never met.
The same heatwave, the same flood, lands on a tier-one life and on someone already trying to make ends meet as two entirely different worlds.
That gap is what I could not put down. It is also, I think, the most badly served problem in corporate social responsibility: enormous budgets moving every year, real work happening on the ground, and almost no ability to say what any of it changed. Programmes designed around what is easy to report rather than what is hard to fix.
So Syntropy Earth builds programmes with the commercial discipline that makes them survive, and not just the conviction that they matter. I run every engagement myself. There is no delivery team the work gets handed to once the proposal is signed.
Background